Literature DB >> 10334252

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

H Tunstall-Pedoe1, K Kuulasmaa, M Mähönen, H Tolonen, E Ruokokoski, P Amouyel.   

Abstract

BACKGROUND: The WHO MONICA (monitoring trends and determinants in cardiovascular disease) Project monitored, from the early 1980s, trends over 10 years in coronary heart disease (CHD) across 37 populations in 21 countries. We aimed to validate trends in mortality, partitioning responsibility between changing coronary-event rates and changing survival.
METHODS: Registers identified non-fatal definite myocardial infarction and definite, possible, or unclassifiable coronary deaths in men and women aged 35-64 years, followed up for 28 days in or out of hospital. We calculated rates from population denominators to estimate trends in age-standardised rates and case fatality (percentage of 28-day fatalities=[100-survival percentage]).
FINDINGS: During 371 population-years, 166,000 events were registered. Official CHD mortality rates, based on death certification, fell (annual changes: men -4.0% [range -10.8 to 3.2]; women -4.0% [-12.7 to 3.0]). By MONICA criteria, CHD mortality rates were higher, but fell less (-2.7% [-8.0 to 4.2] and -2.1% [-8.5 to 4.1]). Changes in non-fatal rates were smaller (-2.1%, [-6.9 to 2.8] and -0.8% [-9.8 to 6.8]). MONICA coronary-event rates (fatal and non-fatal combined) fell more (-2.1% [-6.5 to 2.8] and -1.4% [-6.7 to 2.8]) than case fatality (-0.6% [-4.2 to 3.1] and -0.8% [-4.8 to 2.9]). Contribution to changing CHD mortality varied, but in populations in which mortality decreased, coronary-event rates contributed two thirds and case fatality one third.
INTERPRETATION: Over the decade studied, the 37 populations in the WHO MONICA Project showed substantial contributions from changes in survival, but the major determinant of decline in CHD mortality is whatever drives changing coronary-event rates.

Entities:  

Mesh:

Year:  1999        PMID: 10334252     DOI: 10.1016/s0140-6736(99)04021-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  252 in total

Review 1.  The natural history of acute myocardial infarction.

Authors:  R M Norris
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

2.  Why mortality from heart disease is low in France. Rates of coronary events are similar in France and Southern Europe.

Authors:  P Ducimetière; T Lang; P Amouyel; D Arveiler; J Ferrières
Journal:  BMJ       Date:  2000-01-22

3.  Management of UTI in general practice: a cost effective analysis. A commentary to facilitate an understanding of economic evaluation.

Authors:  D Kernick
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

4.  Statins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable.

Authors:  L D Ritchie
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

5.  The primary prevention of coronary heart disease with statins: practice headache or public health?

Authors:  P H Evans
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

6.  Predicting risk of death from cardiovascular disease. Which measurements are the most appropriate?

Authors:  M J White
Journal:  BMJ       Date:  2001-10-27

7.  Dose dependent but non-linear effects of alcohol on the left and right ventricle.

Authors:  O A Kajander; M Kupari; P Laippala; V Savolainen; J Pajarinen; A Penttilä; P J Karhunen
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

8.  Accelerated publication versus usual publication in 2 leading medical journals.

Authors:  William A Ghali; Jacques Cornuz; Finlay A McAlister; Jean-Blaise Wasserfallen; P J Devereaux; C David Naylor
Journal:  CMAJ       Date:  2002-04-30       Impact factor: 8.262

9.  Reducing the risk of recurrent coronary heart disease. We know a bit more about what doesn't work.

Authors:  F Bradley; M E Cupples
Journal:  BMJ       Date:  1999-06-05

10.  Association of the CCR2 chemokine receptor gene polymorphism with myocardial infarction.

Authors:  M I Voevoda; S N Ustinov; N S Yudin; M M Dolgikh; T N Kuznetsova; V N Maksimov; I V Kulikov; A A Gromov; A V Shabalin; E V Semaeva; V F Kobzev; S R Baum; V V Gafarov; S K Malyutina; A G Romaschenko; YuP Nikitin
Journal:  Dokl Biol Sci       Date:  2002 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.